MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Novalead Pharma

U73100PN2007PTC130929ActivePrivateUnlisted
Last updated: 2026-06-08
30
Compliance Health · F
3 / 9 signals passed

Novalead Pharma is a Private Indian company incorporated in 2007 and based in PN, India. Novalead Pharma operates in R&D (NIC 73100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2007
19 years old
State
PN
Sector
R&D
NIC 73100
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
NovaLead PharmaTRACXN · PUBLIC DATA
Brand NovaLead Pharma · Legal entity Novalead Pharma

NovaLead Pharma - Provider of drug repurposing and discovery through its proprietary technology platform. Raised a total funding of $8.04M over 4 rounds from 5 investors.

Total Funding
Latest Round
Series B
Revenue
Valuation
Funding Rounds
—
Employees
—
Stage
Series B
HQ
Pune
Founded
2007
Source: Tracxn (public profile) · joined to MCA on CIN U73100PN2007PTC130929

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
73100
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
R&D
ROC
—
Website
https://novaleadpharma.com
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
AM
Arun Malhotra
Additional Director
6.5y · New Delhi · DIN 1253113
DR
Deepa Reddy
Director
7.4y · New Delhi · DIN 4619427
Get the full board of directors

Directors, DINs & appointment history for Novalead Pharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 2024+28dfiled
MGT-7FY2024-2524 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 2023+28dfiled
MGT-7FY2023-2424 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2324 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Novalead Pharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
802638902Axis Bank Ltd(Bank)₹11.68 Cr19 Sep 2020Open
224635947ICICI Bank Ltd(Bank)₹7.84 Cr27 Jan 2019Satisfied
232014415State Bank of India(Bank)₹3.79 Cr04 Jul 2021Open
720478883State Bank of India(Bank)₹3.34 Cr04 Jul 2023Satisfied
See registered charges & lenders

Charge IDs, lenders & amounts for Novalead Pharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹12.35 Cr₹1.90 Cr₹8.42 Cr₹16.07 Cr294
FY2023-24₹9.85 Cr₹1.28 Cr₹10.34 Cr₹16.56 Cr316
FY2022-23₹9.78 Cr₹1.61 Cr₹5.18 Cr₹11.79 Cr62
FY2021-22₹6.03 Cr₹77.84 L₹4.78 Cr₹8.79 Cr139
Gain deeper financial insights of this entity

Audited financials & ratios for Novalead Pharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹12.35 Cr₹9.85 Cr₹9.78 Cr₹6.03 Cr
Other income₹13.93 L₹28.31 L₹20.54 L₹17.43 L
Total income₹12.48 Cr₹10.13 Cr₹9.99 Cr₹6.21 Cr
Total expenses₹10.06 Cr₹8.49 Cr₹7.92 Cr₹5.21 Cr
Profit before tax₹2.47 Cr₹1.66 Cr₹2.10 Cr₹1.01 Cr
Profit / (Loss) after tax₹1.90 Cr₹1.28 Cr₹1.61 Cr₹77.84 L
Balance sheet
Equity / Net worth₹8.42 Cr₹10.34 Cr₹5.18 Cr₹4.78 Cr
Borrowings₹2.98 Cr₹1.37 Cr₹1.39 Cr₹1.72 Cr
Current liabilities₹3.61 Cr₹2.56 Cr₹3.59 Cr₹2.16 Cr
Total liabilities₹7.64 Cr₹6.23 Cr₹6.61 Cr₹4.01 Cr
Current assets₹6.26 Cr₹9.78 Cr₹6.84 Cr₹3.58 Cr
Cash & equivalents₹1.59 Cr₹2.71 Cr₹2.23 Cr₹80.21 L
Total assets₹16.07 Cr₹16.56 Cr₹11.79 Cr₹8.79 Cr
Employees29431662139
Gain deeper financial insights of this entity

Audited financials & ratios for Novalead Pharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹12.35 Cr+30.0%+3.5%+7.7%
Profit after Tax₹1.90 Cr+21.3%+24.4%+6.6%
Net Worth₹8.42 Cr-0.5%+15.3%-0.6%
Employees294-3.5%+12.5%+20.0%
Gain deeper financial insights of this entity

Audited financials & ratios for Novalead Pharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹12.35 Cr₹1.90 Cr+15.37%-14.99%+22.52%+11.81%0.35₹4.20 L
FY2023-24₹9.85 Cr₹1.28 Cr+13.00%+37.31%+12.38%+7.73%0.13₹3.12 L
FY2022-23₹9.78 Cr₹1.61 Cr+16.51%+21.10%+31.18%+13.70%0.27₹15.78 L
FY2021-22₹6.03 Cr₹77.84 L+12.90%-12.04%+16.27%+8.86%0.36₹4.34 L
Gain deeper financial insights of this entity

Audited financials & ratios for Novalead Pharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters12,80,99,92666.91%
Institutional Investors258,58,34213.95%
Public & Others6280,38,63219.14%
See the full shareholding pattern

Promoter, institutional & public holding for Novalead Pharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

84 peersSame sector (R&D) — nationwide
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
63
63
Bottom quartile · P8

Top 6 in R&D

by healthView all ›
01
Ecozen Solutions
PN · Inc 2010
Paid-up
Revenue
C · 63
02
Avesthagen
Karnataka · Inc 1998
Paid-up
Revenue
C · 63
03
Pcloudy
Karnataka · Inc 2013
Paid-up
Revenue
C · 63
04
Teamindus
Delhi · Inc 2011
Paid-up
Revenue
C · 63
05
Infollion
Haryana · Inc 2009
Paid-up
Revenue
C · 63
06
Indegene
Karnataka · Inc 1998
Paid-up
Revenue
C · 63

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Novalead Pharma

When was Novalead Pharma incorporated?
Novalead Pharma was incorporated in 2007. Its CIN is U73100PN2007PTC130929 and it is registered with the relevant Registrar of Companies.
Where is Novalead Pharma located?
Novalead Pharma is headquartered in PN.
What sector does Novalead Pharma operate in?
Novalead Pharma operates in the R&D sector (NIC code 73100), classified as Indian Non-Govt Company.
Who are the directors of Novalead Pharma?
Director details for Novalead Pharma have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Novalead Pharma?
Novalead Pharma has authorized capital of — and paid-up capital of —.
Does Novalead Pharma have any open charges?
Novalead Pharma has no open MCA-registered charges on record.
What is Novalead Pharma's Compliance Health Score?
RegisterKaro's Compliance Health Score for Novalead Pharma is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.